CLARIVATE PLC
F:16A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CLARIVATE PLC
F:16A
|
UK |
|
Sagimet Biosciences Inc
F:0O2
|
US |
|
K
|
Kimberly-Clark Corp
XMUN:KMY
|
US |
|
A
|
AAR Corp
F:ARZ
|
US |
|
W
|
Williams-Sonoma Inc
F:WM1
|
US |
|
C
|
Compagnie de Saint Gobain SA
SIX:GOB
|
FR |
Wall St Price Targets
16A Price Targets Summary
CLARIVATE PLC
According to Wall Street analysts, the average 1-year price target for 16A is 4.422 EUR with a low forecast of 3.037 EUR and a high forecast of 7.894 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 16A's stock price target?
Price Target
4.422
EUR
According to Wall Street analysts, the average 1-year price target for 16A is 4.422 EUR with a low forecast of 3.037 EUR and a high forecast of 7.894 EUR.
What is the Revenue forecast for CLARIVATE PLC?
Projected CAGR
-1%
Over the last 7 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is -1%.
What is the Gross Profit forecast for CLARIVATE PLC?
Projected CAGR
0%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 0%.
What is the Operating Income forecast for CLARIVATE PLC?
Projected CAGR
4%
The compound annual growth rate for Operating Income over the next 3 years is 4%.
